BACKGROUND
Anal carcinoma, a common disease in HIV-positive patients, is usually treated with chemoradiotherapy. Generally tolerance was poor before the availability of highly active antiretroviral therapies. We report our experience of treating anal carcinoma in the era of new antiviral drugs.
PATIENTS AND METHODS
Between 1997 and 2001, nine men on highly active antiretroviral therapies with good immune status before chemoradiotherapy received concomitant chemoradiotherapy consisting of 5-fluorouracil and cisplatinum, and high-dose radiotherapy (60–70 Gy) for anal carcinoma. Six cancers were Stage I, two were Stage II, and one was Stage III. CD4+ cell counts were <200/ml for four patients, between 200/ml and 500/ml for four, and >500/ml for one.
RESULTS
All patients received the planned dose of radiation (≥60 Gy). The chemotherapy dose was reduced 25 percent in six patients. Overall treatment time was 58 days. Grade 3 hematologic or skin toxicity occurred in four patients. No association was observed between high-grade toxicity and CD4+ cell count. None of the patients developed opportunistic infections during follow-up. Eight patients were disease-free after a median follow-up of 33 months. Among them, four had no or minor anal function impairment at the last follow-up visit. One patient with T4N2 disease relapsed locally one year after treatment and underwent salvage abdominoperineal excision.
CONCLUSION
High-dose chemoradiotherapy for anal carcinomas is feasible with low toxicity in HIV-positive patients treated with highly active antiretroviral therapies. Local control is similar to that obtained for HIV-negative patients.
Similar content being viewed by others
REFERENCES
D Ryan C Compton R Mayer (2000) ArticleTitleCarcinoma of the anal canal N Engl J Med 342 792–800 Occurrence Handle10.1056/NEJM200003163421107 Occurrence Handle1:STN:280:DC%2BD3c7ms1GqtQ%3D%3D Occurrence Handle10717015
M Frisch R Biggar E Engels J Goedert (2001) ArticleTitleAssociation of cancer with AIDS-related immnosuppression in adults JAMA 285 1736–45 Occurrence Handle10.1001/jama.285.13.1736 Occurrence Handle1:STN:280:DC%2BD3M3hslKrtw%3D%3D Occurrence Handle11277828
M Melbye T Cote L Kessler M Gail R Biggar (1994) ArticleTitleHigh Incidence of anal cancer among AIDS patients: The AIDS/Cancer Working group Lancet 343 636–9 Occurrence Handle10.1016/S0140-6736(94)92636-0 Occurrence Handle1:STN:280:ByuC2Mflt1U%3D Occurrence Handle7906812
M Frisch B Glimelius A van den Brule et al. (1997) ArticleTitleSexually transmitted infection as a cause of anal cancer N Engl J Med 337 1350–8 Occurrence Handle10.1056/NEJM199711063371904 Occurrence Handle1:STN:280:DyaK1c%2FgtVSjtg%3D%3D Occurrence Handle9358129
P Tilston (1997) ArticleTitleAnal human papillomavirus and anal cancer J Clin Pathol 50 625–34 Occurrence Handle1:STN:280:ByiH2cjgvFc%3D Occurrence Handle9301544
A Beckmann J Daling K Sherman et al. (1999) ArticleTitleHuman papillomavirus infection and anal cancer Int J Cancer 43 1042–9
M Melbye C Rabkin M Frisch R Biggar (1994) ArticleTitleChanging patterns of anal cancer incidence in the United States, 1940-1989 Am J Epidemiol 139 772–80 Occurrence Handle1:STN:280:ByuB3svhtVI%3D Occurrence Handle8178790
J Palefsky E Holly M Ralston N Jay J Berry T Darragh (1998) ArticleTitleHigh incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men AIDS 12 495–503 Occurrence Handle10.1097/00002030-199805000-00011 Occurrence Handle1:STN:280:DyaK1c3gt1Cmsg%3D%3D Occurrence Handle9543448
C Critchlow C Surawicz K Holmes et al. (1995) ArticleTitleProspective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection AIDS 9 1255–62 Occurrence Handle1:STN:280:BymC38nhvVQ%3D Occurrence Handle8561979
J Palefsky E Holly M Ralston T Darragh N Jay M Berry (1999) ArticleTitleThe effect of HAART on the natural history of anal squamous intraepithelial lesion in HIV+ men [abstract] J Acquir Immune Defic Syndr 21 A13
H Bartelink F Roelofsen F Eschwege et al. (1997) ArticleTitleConcomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer: Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 2040–9 Occurrence Handle1:CAS:528:DyaK2sXjsVCrt7k%3D Occurrence Handle9164216
InstitutionalAuthorNameUKCCCR Anal Cancer Trial Working Party (1996) ArticleTitleEpidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1049–54
J Holland P Swift (1994) ArticleTitleTolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy Radiology 193 251–4 Occurrence Handle1:STN:280:ByuA2sjmtlw%3D Occurrence Handle8090901
M Chadha E Rosenblatt S Malamud J Pisch A Berson (1994) ArticleTitleSquamous-cell carcinoma of the anus in HIV-positive patients Dis Colon Rectum 37 861–5 Occurrence Handle1:STN:280:ByuA2MjgtlA%3D Occurrence Handle8076484
InstitutionalAuthorNameWorld Health Organization. (1979) WHO handbook for reporting results of cancer treatment World Health Organization Geneva
R Doci R Zucali G Monica ParticleLa et al. (1996) ArticleTitlePrimary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients J Clin Oncol 14 3121–5 Occurrence Handle1:CAS:528:DyaK2sXitl2itg%3D%3D Occurrence Handle8955657
J Gerard L Ayzac D Hun et al. (1998) ArticleTitleTreatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients Radiother Oncol 46 249–56 Occurrence Handle10.1016/S0167-8140(97)00192-8 Occurrence Handle1:CAS:528:DyaK1cXht1Wlurc%3D Occurrence Handle9572617
D Peiffert M Giovannini M Ducreux et al. (2001) ArticleTitleHigh-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anala cancer: final results of a phase II study Ann Oncol 12 397–404 Occurrence Handle10.1023/A:1011107105538 Occurrence Handle1:STN:280:DC%2BD3MrhsFCitg%3D%3D Occurrence Handle11332154
T Rich J Ajani W Morrison D Ota B Levin (1993) ArticleTitleChemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin Radiother Oncol 27 209–15 Occurrence Handle1:STN:280:ByuD38zgs10%3D Occurrence Handle8210457
R Myerson S Shapiro D Lacey et al. (1995) ArticleTitleCarcinoma of the anal canal Am J Clin Oncol 18 32–9 Occurrence Handle1:STN:280:ByqC2cbptVc%3D Occurrence Handle7847256
D Bottomley N Aqel G Selvaratnam R Phillips (1996) ArticleTitleEpidermoid anal cancer in HIV infected patients Clin Oncol (R Coll Radiol) 8 319–22 Occurrence Handle1:STN:280:ByiD1cfhtFA%3D
S Hocht T Wiegel A Kroesen W Berdel N Runnel W Hinkelbein (1997) ArticleTitleLow acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal cancer and HIV-infection Acta Oncol 36 799–802
A Peddada D Smith A Kroesen A Rao D Frost A Kagan (1997) ArticleTitleChemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal Int J Radiat Oncol Biol Phys 37 1101–5
R Hoffman M Welton B Klencke V Weinberg R Krieg (1999) ArticleTitleThe significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer Int J Radiat Oncol Biol Phys 44 127–31
S Cleator K Fife M Nelson B Gazzard R Phillips M Bower (2000) ArticleTitleTreatment of HIV-associated invasive anal cancer with combined chemoradiation Eur J Cancer 36 754–8
RJ Place SG Gregorcyk PJ Huber CL Simmang (2001) ArticleTitleOutcome analysis of HIV-positive patients with anal squamous cell carcinoma Dis Colon Rectum 44 506–12 Occurrence Handle1:STN:280:DC%2BD3M3jvVGgsQ%3D%3D Occurrence Handle11330577
S Formenti L Chak P Gill E Buess C Hill (1995) ArticleTitleIncreased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi-s sarcoma Int J Radiat Biol 68 411–2 Occurrence Handle1:CAS:528:DyaK2MXpsVKjsr8%3D Occurrence Handle7594966
B Vatra I Sobhani T Aparicio et al. (2001) ArticleTitleAnal canal squamous-cell carcinomas in HIV-positive patients: clinical features, treatments and prognosis Gastroenterol Clin Biol 25 150–6
B Klencke (2002) Anal cancer: a human immunodeficiency virus-associated cancer ASCO 2002 Educational Booklet . . 260–5
A Allal B Mermillod A Roth M Marti J Kurtz (1997) ArticleTitleImpact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma Int J Radiat Oncol Biol Phys 39 1099–105 Occurrence Handle10.1016/S0360-3016(97)00390-8 Occurrence Handle1:STN:280:DyaK1c%2Flt1CnsQ%3D%3D Occurrence Handle9392550
P Broens E Limbergen Particlevan F Penninckx R Kerremans (1998) ArticleTitleClinical and manometric effects of combined external beam irradiation and brachytherapy for anal cancer Int J Colorectal Dis 13 68–72
D Vordermark M Sailer M Flentje A Thiede O Kolbl (1999) ArticleTitleCurative-intent radiation therapy in anal carcinoma: quality of life and sphincter function Radiother Oncol 52 239–43 Occurrence Handle10.1016/S0167-8140(99)00096-1 Occurrence Handle1:STN:280:DC%2BD3c%2Fks1ygtQ%3D%3D Occurrence Handle10580870
E Deniaud-Alexandre E Touboul E Tiret et al. (2003) ArticleTitleResults of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal Int J Radiat Oncol Biol Phys 56 1259–73
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Blazy, A., Hennequin, C., Gornet, JM. et al. Anal Carcinomas in HIV-Positive Patients: High-Dose Chemoradiotherapy Is Feasible in the Era of Highly Active Antiretroviral Therapy. Dis Colon Rectum 48, 1176–1181 (2005). https://doi.org/10.1007/s10350-004-0910-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-0910-7